Microenvironment-responsive drug delivery systems (DDSs) can achieve targeted drug
delivery, reduce drug side effects and improve drug efficacies. Among them, pH-responsive …

Despite the exciting breakthroughs in medical technology, cancer still accounts for one of
the principle triggers of death and conventional therapeutic modalities often fail to attain an …

A unique robotic medical platform is designed by utilizing cell robots as the active “Trojan
horse” of oncolytic adenovirus (OA), capable of tumor‐selective binding and killing. The OA …

Integrins mediate adhesive interactions between cells and their environment, including
neighboring cells and extracellular matrix (ECM). These heterodimeric transmembrane …

Despite the encouraging breakthroughs in medical development, cancer remains one of the
principle causes of death and threatens human health around the world. Conventional …

Although various treatments are currently being developed, lung cancer still has a very high
mortality rate. Moreover, while various strategies for the diagnosis and treatment of lung …

Most anticancer drugs often fail in clinical trials due to poor solubility, poor bioavailability,
lack of targeted delivery and several off-target effects. Polymeric nanoparticles such as poly …

With the continuous increasing number of cancer patients worldwide, there has been great
interest in developing the targeted delivery anti-cancer drugs. The drug concentration …

Simple Summary Pancreatic cancer (PC) is a highly aggressive malignant tumor with an
extremely poor prognosis. Early diagnosis and treatment are key to improving the survival …

The recent progress in nanoparticle applications, such as tumor-targeting, has enabled
specific delivery of chemotherapeutics to malignant tissues with enhanced local efficacy …